MENU

Welcome to the ORIC - Research Compliance Administration

Information you will find on this website includes, but is not limited to, the following:

  • Conflicts of interest disclosure requirements for faculty and EHRA non-faculty;
  • Conflicts of interest disclosure requirements for those engaging in federally funded research;
  • Develop and enforce conflicts of interest management plans, to protect ECU faculty, staff, and students and the institution;
  • Information and disclosure requirements regarding external professional activities for pay;
  • Information and guidance on export control regulations and assist with license applications; and
  • Responsible conduct of research instruction for faculty, staff, postdoctoral scholars, and students.

ORIC is dedicated to cultivating a culture of ethics, integrity, and compliance with applicable laws, regulations, and policies.  We invite faculty, staff, researchers, and students to contact us for assistance with training, policies, procedures, or consultations.  Our office has an open-door policy; we welcome all calls, emails, and in-person inquiries.

Quick Links

Announcements

  • Changes to the federal rule governing human research (Common Rule) were announced on January 18, 2017. Many of the Common Rule changes go into effect January 19, 2018. 
  • The changes to the Common rule do not apply to FDA-regulated studies. 
  • ORIC is working to roll out these changes at ECU. The announcements section of the ORIC > UMCIRB webpage and the ePIRATE homepage will be your main source for information and updates about the revised Common Rule roll out. 
  • Studies submitted on or after January 19, 2018 will be reviewed under the revised Common Rule. We are currently evaluating whether the changes will apply to studies existing prior to January 19, 2018. 
  • The definition of "human subject" has been altered to now include identifiable biospecimens. Identifiable biospecimens and identifiable private information are treated the same in the final rule. 
  • Consent forms will need to include an introductory paragraph which provides a clear and easy to understand summary of the key information that will be helpful to a potential participant or their legally authorized representative in the understanding of reasons why they might or why they might not want to take part in the research. 
  • Overall, there are four new elements of informed consent; one new required element and three new optional (i.e."if applicable") elements. These new elements are generally related to the secondary use of data and samples and genomic research. 
  • The revisions to the Common Rule broaden the types of research that can be reviewed under the exempt categories. For example, secondary research involving identifiable private information that is protected by HIPAA can be reviewed under an exempt category; currently this type of research requires review under an expedited category. As has always been the case at ECU, only the IRB may determine what research may be reviewed under the exempt categories. 
  • Some minimal risk studies will no longer be required to undergo annual continuing review. 
  • Changes to the Common Rule mandate the use of a single IRB for multisite, cooperative studies. This requirement will be effective January 19, 2020
  • The revisions to the Common Rule go into effect January 19, 2018 and UMCIRB will begin reviewing new studies under the revised Common Rule on that date. 
  • New document templates will be posted on both the UMCIRB website and within ePIRATE. Be sure to use these new templates for any new research studies submitted on or after 01.19.18. 
  • Revised SOPs will be posted on the UMCIRB website.
  • Existing expedited studies approved prior to January 19, 2018 will continue to follow pre-2018 requirements including required renewal at least annually. Upon request by the investigator and after discussion with ORIC, an existing study may be revised to meet the new federal requirements. An amendment would need to be submitted and approved within the electronic IRB submission system to document this transition.
  • Keep our website and the ePIRATE homepage checked for continuing and updated information.
  • Contact UMCIRB with any questions. You are welcome to email us at UMCIRB@ecu.edu
  • Remember, the revised Common Rule does not apply to FDA-regulated studies. 

If you will be traveling internationally on behalf of ECU, please submit a completed International Travel form for export control review and approval. Please submit this form as soon as you become aware that you will be traveling internationally. Click here to access the form.

Staff Contacts

Norma Epley
Director
252-744-1971

Sierra Fountain
University Program Associate, COI
252-328-9473

RGS Road Map